HUP0004511A2 - Integrin inhibitor hatású ciklopeptidszármazékok, eljárás ilyen származékok előállítására és alkalmazásuk - Google Patents

Integrin inhibitor hatású ciklopeptidszármazékok, eljárás ilyen származékok előállítására és alkalmazásuk

Info

Publication number
HUP0004511A2
HUP0004511A2 HU0004511A HUP0004511A HUP0004511A2 HU P0004511 A2 HUP0004511 A2 HU P0004511A2 HU 0004511 A HU0004511 A HU 0004511A HU P0004511 A HUP0004511 A HU P0004511A HU P0004511 A2 HUP0004511 A2 HU P0004511A2
Authority
HU
Hungary
Prior art keywords
general formula
cyclopeptide derivatives
preparation
integrin inhibitor
ch2ch2
Prior art date
Application number
HU0004511A
Other languages
English (en)
Inventor
Dirk Finsinger
Alfred Jonczyk
Martin Kantlehner
Horst Kessler
Jörg Meyer
Berthold Nies
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0004511A2 publication Critical patent/HUP0004511A2/hu
Publication of HUP0004511A3 publication Critical patent/HUP0004511A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/10Process efficiency

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány ciklopeptidszármazékokra, azok alkalmazására, valamintelőállításukra alkalmas eljárásra vonatkozik. A találmány szerinticiklopeptidszármazékok R-Q-X (I) általános képletében aszubsztituensek főbb jelentései: - R jelentése ciklo[Arg-Gly-Asp-Z)általános képletű csoport, - Q nincs jelen, vagy pedig jelentése -[CO-R1-NH-]m, -[NH-R1-CO-]m, -[CO-R1-CO-]m vagy -(CO-CH2-O-CH2CH2-O- -CH2CH2-NH-)n-[CO-R-NH-]m általános képletű csoport; - X jelentése -CO-CH=CH2, -CO-C(CH3)=CH2, -NH-CH=CH2, -NH-C(CH3)=CH2 vagy -NH-(CH2)p-SR10 általános képletű csoport, - Z jelentése - a többiaminosavmaradéktól függetlenül - aminosav-, dipeptid- vagytripeptidmaradék; - m és n jelentése - egymástól függetlenül - 0, 1, 2vagy 3. A találmány szerinti vegyületek integrin-inhibitorokkénthasználhatók implantátumok által előidézett rendellenességekkezelésére, valamint implantátumok vagy biokompatibilis felületekszövetekbe való beépülését eredményező folyamat gyorsítására éselősegítésére. Ó
HU0004511A 1997-12-16 1998-12-09 Cyclopeptide derivatives with integrin inhibitor properties, process for preparation thereof and their use HUP0004511A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19755800A DE19755800A1 (de) 1997-12-16 1997-12-16 Cyclopeptidderivate
PCT/EP1998/008003 WO1999031126A1 (de) 1997-12-16 1998-12-09 Cyclopeptidderivate mit integrin-inhibitor-eigenschaften

Publications (2)

Publication Number Publication Date
HUP0004511A2 true HUP0004511A2 (hu) 2001-06-28
HUP0004511A3 HUP0004511A3 (en) 2001-12-28

Family

ID=7852041

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004511A HUP0004511A3 (en) 1997-12-16 1998-12-09 Cyclopeptide derivatives with integrin inhibitor properties, process for preparation thereof and their use

Country Status (14)

Country Link
US (2) US6610826B1 (hu)
EP (1) EP1037906B1 (hu)
JP (1) JP3844655B2 (hu)
KR (1) KR20010033103A (hu)
CN (1) CN1282337A (hu)
AT (1) ATE289320T1 (hu)
AU (1) AU735386B2 (hu)
CA (1) CA2315532C (hu)
DE (2) DE19755800A1 (hu)
ES (1) ES2237857T3 (hu)
HU (1) HUP0004511A3 (hu)
PL (1) PL340502A1 (hu)
WO (1) WO1999031126A1 (hu)
ZA (1) ZA9811462B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815900B1 (en) 2000-07-11 2010-10-19 L'ORéAL S.A. Use of C3-C5 monosaccharides to protect keratinous fibers
DE10040103A1 (de) * 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II
DE10040105A1 (de) * 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
WO2002040073A1 (en) 2000-11-20 2002-05-23 Université De Genève Endosseous implant
DE10325049A1 (de) * 2003-06-02 2004-12-23 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III
PT2484365E (pt) 2004-06-04 2013-12-12 Scripps Research Inst Composições e métodos para o tratamento de doenças neovasculares
JP5560393B2 (ja) * 2005-06-22 2014-07-23 アステリアス バイオセラピューティクス インコーポレイテッド 心筋細胞系列細胞への霊長類多能性幹細胞の分化
AU2009209167B8 (en) * 2008-01-30 2015-04-02 Asterias Biotherapeutics, Inc. Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
AU2009209157B2 (en) 2008-01-30 2015-06-11 Asterias Biotherapeutics, Inc. Synthetic surfaces for culturing stem cell derived cardiomyocytes
EP2259768B1 (en) 2008-04-08 2019-05-22 Merck Patent GmbH Compositions containing cyclic peptides and methods of use
US20110183418A1 (en) * 2009-07-29 2011-07-28 Arthur Winston Martin Peptide-Polymer Cell Culture Articles and Methods of Making

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538741A1 (de) 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
EP0844252A3 (en) 1996-11-15 1998-07-08 Remacle, José Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
DE19725368A1 (de) * 1997-06-16 1998-12-17 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren und deren Verwendung für bildgebende Verfahren

Also Published As

Publication number Publication date
PL340502A1 (en) 2001-02-12
ZA9811462B (en) 1999-06-15
EP1037906A1 (de) 2000-09-27
DE19755800A1 (de) 1999-06-17
US20020198142A1 (en) 2002-12-26
JP3844655B2 (ja) 2006-11-15
US6610826B1 (en) 2003-08-26
KR20010033103A (ko) 2001-04-25
EP1037906B1 (de) 2005-02-16
US6995238B2 (en) 2006-02-07
AU735386B2 (en) 2001-07-05
JP2002508392A (ja) 2002-03-19
DE59812581D1 (de) 2005-03-24
ATE289320T1 (de) 2005-03-15
AU2268999A (en) 1999-07-05
ES2237857T3 (es) 2005-08-01
HUP0004511A3 (en) 2001-12-28
WO1999031126A1 (de) 1999-06-24
CN1282337A (zh) 2001-01-31
CA2315532C (en) 2008-02-12
CA2315532A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
ES2285859T3 (es) Utilizacion cosmetica o dermofarmaceutica de peptidos para la cicatrizacion, la hidratacion y la mejora del aspecto cutaneo durante el envejecimiento natural o acelerado (heliodermia, contaminacion).
CA2655116C (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
US5739111A (en) Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
US20060105006A1 (en) Use of metalloprotease inhibitors to induce and/or stimulate the growth of head hair or other hairs and/or to slow down their loss
FR2676922B1 (fr) Applications en cosmetique de derives n-acyles de melanges d'acides amines issus d'hydrolysats de proteines vegetales.
HUP0004511A2 (hu) Integrin inhibitor hatású ciklopeptidszármazékok, eljárás ilyen származékok előállítására és alkalmazásuk
ATE218336T1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
US20070116659A1 (en) Elastase inhibitor
MY115211A (en) Novel amino acid derivatives, their preparation and use
HK1079549A1 (en) Muteins of placental growth factor type 1, preparation method and application thereof
JPH0322993A (ja) 水溶性l−チロシン誘導体およびl−チロシン誘導体の製造方法
WO2001091700A2 (en) Composition and method for enhancing elasticity of tissue
AU2001275018A1 (en) Composition and method for enhancing elasticity of tissue
ID28365A (id) Turunan produk alami yang baru
DE50207740D1 (de) Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
ES2135695T3 (es) Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2.
ITMI982746A1 (it) Composizione farmaceuticia a base di prolina, glicina e lisina utilenella terapia odontoiatrica sia sotto forma iniettabile che in
JP5216414B2 (ja) 育毛剤
JP5166116B2 (ja) 育毛剤
JP2009091325A (ja) 育毛剤
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
HUP9801810A2 (hu) Imidazo[1,5-a]piridin-csoporttal helyettesített szerin-proteáz inhibitorok, ezek előállítása és ezeket tartalmazó gyógyszerkészítmények
DE69630876D1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8